BGF MDI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BGF MDI, covering 2024-07-29 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD). [Phase 3]